[go: up one dir, main page]

CN118845297A - One-time implantation of artificial cornea and method of use thereof - Google Patents

One-time implantation of artificial cornea and method of use thereof Download PDF

Info

Publication number
CN118845297A
CN118845297A CN202411029920.6A CN202411029920A CN118845297A CN 118845297 A CN118845297 A CN 118845297A CN 202411029920 A CN202411029920 A CN 202411029920A CN 118845297 A CN118845297 A CN 118845297A
Authority
CN
China
Prior art keywords
cornea
bracket
artificial
time
column body
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202411029920.6A
Other languages
Chinese (zh)
Other versions
CN118845297B (en
Inventor
黄一飞
王丽强
刘安琪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Third Medical Center of PLA General Hospital
Original Assignee
Third Medical Center of PLA General Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Third Medical Center of PLA General Hospital filed Critical Third Medical Center of PLA General Hospital
Priority to CN202411029920.6A priority Critical patent/CN118845297B/en
Publication of CN118845297A publication Critical patent/CN118845297A/en
Application granted granted Critical
Publication of CN118845297B publication Critical patent/CN118845297B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses or corneal implants; Artificial eyes
    • A61F2/142Cornea, e.g. artificial corneae, keratoprostheses or corneal implants for repair of defective corneal tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses or corneal implants; Artificial eyes
    • A61F2/148Implantation instruments specially adapted therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)

Abstract

本发明公开一种一次植入人工角膜,属于体内假体植入技术领域。至少解决现有技术存在的需要供体角膜、多次手术、创伤大且不适用于患有严重角膜盲患者等问题。一次植入人工角膜包括支架和镜柱,镜柱包括镜柱本体以及同轴设置在镜柱本体靠近后端面处的后盘;镜柱与支架同轴可拆卸的连接;使用状态下,位于后盘后的镜柱本体的后端凸入眼内,后盘贴合角膜后表面且支架贴合角膜前表面,应用缝合方法将支架固定在角膜表面,同时,支架和后盘一前一后夹持角膜。本发明还提供一种一次植入人工角膜的使用方法。具有一次植入、无需供体角膜、创伤小以及适用于患有严重角膜盲患者等优点,应用前景广阔。

The present invention discloses a one-time implantable artificial cornea, belonging to the technical field of in vivo prosthesis implantation. At least the problems existing in the prior art, such as the need for a donor cornea, multiple surgeries, large trauma, and not suitable for patients with severe corneal blindness, are solved. The one-time implantable artificial cornea includes a bracket and a mirror column, the mirror column includes a mirror column body and a rear disc coaxially arranged at the rear end surface of the mirror column body; the mirror column and the bracket are coaxially detachably connected; in the use state, the rear end of the mirror column body located behind the rear disc protrudes into the eye, the rear disc fits the rear surface of the cornea and the bracket fits the front surface of the cornea, the bracket is fixed to the corneal surface by a suturing method, and at the same time, the bracket and the rear disc clamp the cornea one after the other. The present invention also provides a method for using the one-time implantable artificial cornea. It has the advantages of one-time implantation, no need for a donor cornea, small trauma, and being suitable for patients with severe corneal blindness, and has broad application prospects.

Description

一种一次植入人工角膜及其使用方法One-time implantation of artificial cornea and method of use thereof

技术领域Technical Field

本发明属于体内假体植入技术领域,尤其涉及一种一次植入人工角膜及其使用方法。The invention belongs to the technical field of in vivo prosthesis implantation, and in particular relates to a one-time implantation artificial cornea and a use method thereof.

背景技术Background Art

人工角膜,指用生物医学材料制成的一种特殊屈光装置,用以替代病变后阻碍眼球光学通路的混浊角膜,使患者获得一定视力。An artificial cornea refers to a special refractive device made of biomedical materials, which is used to replace the cloudy cornea that blocks the optical pathway of the eye after a disease, so that the patient can regain a certain degree of vision.

现有技术提供一种人工角膜,脱盲率可达79.9%,是目前国际上使用最多的人工角膜。该人工角膜在治疗过程中不仅需要全身麻醉,而且术中需要使用环钻切除大直径全层角膜,术中发生严重并发症的风险高。特别是,需要使用供体角膜植片做载体,而供体角膜严重匮乏是我国目前难以解决的问题,因此,该人工角膜无法规模化开展移植手术。此外该人工角膜术后需要长期局部使用激素或免疫抑制剂,感染和青光眼发生率高,远期视力维持困难。此外,由于具有大直径后盘,人工角膜后膜发生率高,不仅严重威胁视力,而且,角膜植片溶解的并发症发生率高。同时,又增加了青光眼发生的风险。此外,该人工角膜对于眼表条件要求高,即需要良好的泪液功能以及要求眼睑和结膜囊具有较好的完整性,特别是对自身免疫性疾病引起的干眼愈后极差。再者,发生穿孔漏水需要紧急更换新的人工角膜,而如果没有供体角膜植片,则无法进行紧急抢救。The prior art provides an artificial cornea with a blindness-free rate of up to 79.9%, which is currently the most widely used artificial cornea in the world. The artificial cornea not only requires general anesthesia during the treatment process, but also requires the use of a trephine to remove the large-diameter full-thickness cornea during the operation, and the risk of serious complications during the operation is high. In particular, a donor corneal graft is required as a carrier, and the severe shortage of donor corneas is a problem that is difficult to solve in my country at present. Therefore, the artificial cornea cannot be transplanted on a large scale. In addition, the artificial cornea requires long-term local use of hormones or immunosuppressants after surgery, and the incidence of infection and glaucoma is high, and it is difficult to maintain long-term vision. In addition, due to the large-diameter posterior disc, the incidence of posterior membrane of the artificial cornea is high, which not only seriously threatens vision, but also has a high incidence of complications of corneal graft dissolution. At the same time, the risk of glaucoma is increased. In addition, the artificial cornea has high requirements for ocular surface conditions, that is, it requires good tear function and requires the eyelids and conjunctival sac to have good integrity, especially for dry eyes caused by autoimmune diseases. The recovery is extremely poor. Furthermore, if perforation and leakage occur, a new artificial cornea needs to be replaced urgently, but if there is no donor corneal graft, emergency rescue cannot be performed.

现有技术还提供另外一种人工角膜,脱盲率为86.6%。而且能够适用于严重眼表疾病、化学伤、热烧伤、爆炸伤、眼睑闭锁以及终末期干眼等双眼盲患者。但是,需要两期手术,即Ⅰ期手术进行支架植入,Ⅱ期手术进行镜柱植入。手术技术推广困难,主要在于角膜板层分离困难,容易发生术中角膜穿孔而导致支架植入失败。Ⅱ期术中术野小,晶状体摘除极为困难,晶体皮质残留发生率高,可引起晶体源性炎症反应,威胁视功能。开展这类手术,手术学习曲线长,要求术者具有全面的手术技能,因此,难以掌握及广泛推广。另外,镜柱以螺扣的方式固定,容易发生脱落,一旦脱落将会导致严重后果。支架与镜柱的连接件是由后向前卡入,Ⅱ期镜柱则由前向后植入,植入过程中,施加在支架上的力可能导致连接件脱落,进而造成无法植入镜柱的窘境。The existing technology also provides another artificial cornea with a blindness-free rate of 86.6%. It can also be used for patients with bilateral blindness such as severe ocular surface diseases, chemical injuries, thermal burns, blast injuries, eyelid closure, and terminal dry eyes. However, two-stage surgery is required, namely, stage I surgery for stent implantation and stage II surgery for lens column implantation. The difficulty in promoting surgical technology is mainly due to the difficulty in separating the corneal lamellae, which is prone to corneal perforation during surgery and leads to failure of stent implantation. The surgical field is small during stage II surgery, and lens removal is extremely difficult. The incidence of residual lens cortex is high, which can cause lens-derived inflammatory response and threaten visual function. For this type of surgery, the surgical learning curve is long and requires the surgeon to have comprehensive surgical skills. Therefore, it is difficult to master and widely promote. In addition, the lens column is fixed in a screw buckle manner, which is easy to fall off, and once it falls off, it will lead to serious consequences. The connector between the stent and the lens column is inserted from back to front, and the stage II lens column is implanted from front to back. During the implantation process, the force applied to the stent may cause the connector to fall off, resulting in the dilemma of being unable to implant the lens column.

鉴于此,亟待提出一种能够克服上述技术问题的一次植入即可完成角膜盲复明治疗的人工角膜。In view of this, it is urgent to propose an artificial cornea that can overcome the above-mentioned technical problems and complete corneal blindness restoration treatment with a single implant.

发明内容Summary of the invention

本发明的目的在于提供一种一次植入人工角膜及其使用方法,能有效解决现有技术存在的需要供体角膜、多次手术分别植入支架和镜柱、晶状体摘除困难及皮质残留发生率高、不适用于重症眼表疾病患者等问题。The purpose of the present invention is to provide a one-time implantation artificial cornea and a method of using the same, which can effectively solve the problems existing in the prior art, such as the need for a donor cornea, multiple surgeries to implant the stent and lens column separately, difficulty in lens removal, high incidence of cortical residues, and unsuitability for patients with severe ocular surface diseases.

为了实现上述目的,本发明提供如下技术方案:In order to achieve the above object, the present invention provides the following technical solutions:

第一方面,本发明提供一种一次植入人工角膜,包括支架和镜柱,镜柱包括镜柱本体以及同轴设置在镜柱本体靠近后端面处的后盘;镜柱与支架同轴可拆卸的连接;使用状态下,位于后盘后的镜柱本体的后端凸入眼内,后盘贴合角膜后表面且支架贴合角膜前表面,应用缝合方法将支架固定在角膜表面,同时,支架和后盘前后夹持角膜。In the first aspect, the present invention provides a one-time implantable artificial cornea, comprising a bracket and a lens column, the lens column comprising a lens column body and a rear disk coaxially arranged at the rear end surface of the lens column body; the lens column and the bracket are coaxially detachably connected; in the use state, the rear end of the lens column body located behind the rear disk protrudes into the eye, the rear disk fits the rear surface of the cornea and the bracket fits the front surface of the cornea, the bracket is fixed to the corneal surface by a suturing method, and at the same time, the bracket and the rear disk clamp the cornea front and back.

采用上述技术方案的情况下,通过如下方式将本发明提供的人工角膜植入严重角膜盲患者的眼内,达到复明的目的。即在患者角膜中央利用环钻打孔,并在孔的一侧侧切以形成角膜放射状侧切口,改善手术视野,便于晶体完整取出,解决了现有技术存在的晶体皮质残留的问题。When the above technical solution is adopted, the artificial cornea provided by the present invention is implanted into the eyes of patients with severe corneal blindness in the following manner to achieve the purpose of restoring sight: a hole is drilled in the center of the patient's cornea, and a side cut is made on one side of the hole to form a radial side incision of the cornea, thereby improving the surgical field of view, facilitating the complete removal of the lens, and solving the problem of residual lens cortex in the prior art.

取出晶状体以及切除前部玻璃体后,将人工角膜所包括得后盘植入上述钻孔内,即后盘通过角膜放射状侧切口进入角膜后与其后表面贴合。此时,可以将角膜放射状侧切口缝合,以使镜柱初步固定。在此基础上,旋转支架,以使支架向后移动,当支架与角膜前表面贴合时,支架和后盘一前一后夹持在角膜上,将支架与角膜缝合在一起,以实现支架在眼表的固定。After removing the lens and removing the anterior vitreous body, the posterior disc included in the artificial cornea is implanted into the above-mentioned drill hole, that is, the posterior disc enters the cornea through the radial side incision of the cornea and fits with its posterior surface. At this time, the radial side incision of the cornea can be sutured to initially fix the lens column. On this basis, the bracket is rotated to move the bracket backward. When the bracket fits with the anterior surface of the cornea, the bracket and the posterior disc are clamped on the cornea one after the other, and the bracket and the cornea are sutured together to achieve the fixation of the bracket on the ocular surface.

从上述应用过程可知,本发明提供的人工角膜仅需要一次手术即可完成植入,手术周期短,能够降低患者等待的焦虑和多次手术的痛苦。而且,利用患者自体角膜实现对支架的初步固定,无需供体角膜,可以完全避免供体角膜缺乏及异体角膜移植排斥的问题。另外,支架位于角膜前表面,相对于现有技术提供的支架植入角膜板层内,手术难度和风险大大降低、创伤小以及愈合周期短且愈合效果好。From the above application process, it can be seen that the artificial cornea provided by the present invention only requires one operation to complete the implantation, and the operation cycle is short, which can reduce the patient's anxiety of waiting and the pain of multiple operations. Moreover, the initial fixation of the stent is achieved by using the patient's own cornea, without the need for a donor cornea, which can completely avoid the problems of donor cornea shortage and allogeneic corneal transplant rejection. In addition, the stent is located on the front surface of the cornea, and compared with the stent provided by the prior art that is implanted in the corneal lamella, the difficulty and risk of the operation are greatly reduced, the trauma is small, the healing cycle is short, and the healing effect is good.

作为一种可能的实现方式,后盘后方的镜柱本体的侧面底端至后端面为方边。如此设置,镜柱侧壁的生物组织较难越过方边向镜柱后端面生长,即能够有效防止人工角膜后膜形成,从而规避镜柱无法透光的问题。As a possible implementation method, the side bottom end to the rear end face of the lens column body behind the rear disc is a square edge. In this way, it is difficult for biological tissue on the side wall of the lens column to grow beyond the square edge to the rear end face of the lens column, which can effectively prevent the formation of the posterior membrane of the artificial cornea, thereby avoiding the problem that the lens column cannot transmit light.

作为一种可能的实现方式,后盘的外周向前设置有环形外沿,以封闭后盘与角膜后表面。As a possible implementation, an annular outer edge is provided forwardly on the periphery of the posterior disc to seal the posterior disc and the posterior surface of the cornea.

作为一种可能的实现方式,方边为直角边、钝角边或锐角边中的一种。As a possible implementation manner, the square edge is one of a right-angled edge, an obtuse-angled edge, or an acute-angled edge.

作为一种可能的实现方式,后盘后方的镜柱本体为等径结构、直径逐渐缩小的结构或直径逐渐增大的结构中的一种。As a possible implementation manner, the mirror column body behind the rear disc is one of a structure with a constant diameter, a structure with a gradually decreasing diameter, or a structure with a gradually increasing diameter.

作为一种可能的实现方式,角膜前表面缝合有用于加固支架的生物组织或人工合成材料。其中,所述生物组织由内至外依次包括耳软骨和Tenon's囊;所述人工合成材料为羟基磷灰石、人工骨。As a possible implementation method, the front surface of the cornea is sutured with biological tissue or artificial synthetic material for reinforcing the bracket. The biological tissue includes ear cartilage and Tenon's capsule from the inside to the outside; the artificial synthetic material is hydroxyapatite and artificial bone.

在实际应用中,取自患者的耳软骨,耳软骨中央开孔,套入镜柱,使耳软骨包绕镜柱且覆盖支架,缝合固定在眼表,实现对人工角膜的加固,使得人工角膜更加稳固,不易脱位。另外,角膜被耳软骨覆盖后,相当于其上覆盖有屏障,不仅起到保护的作用,而且能够避免角膜溶解。In actual application, the ear cartilage is taken from the patient, a hole is made in the center of the ear cartilage, and the lens column is inserted so that the ear cartilage surrounds the lens column and covers the bracket, and is sutured and fixed to the eye surface to reinforce the artificial cornea, making the artificial cornea more stable and less likely to dislocate. In addition, after the cornea is covered with ear cartilage, it is equivalent to covering it with a barrier, which not only plays a protective role, but also can prevent the cornea from dissolving.

在耳软骨的前表面,还进一步的覆盖有Tenon's囊实现对耳软骨的固定以及为耳软骨提供营养,使组织更好愈合。Tenon's囊表面用结膜、口唇黏膜或眼睑皮肤覆盖,达到表面上皮化,能够有效抵抗组织溶解以及抗感染。The front surface of the ear cartilage is further covered with Tenon's capsule to fix the ear cartilage and provide nutrition to the ear cartilage, so that the tissue can heal better. The surface of Tenon's capsule is covered with conjunctiva, oral mucosa or eyelid skin to achieve surface epithelialization, which can effectively resist tissue dissolution and infection.

作为一种可能的实现方式,支架为金属支架,镜柱为聚甲基丙烯酸羟乙酯、聚甲基丙烯酸甲酯、生物陶瓷或光学玻璃中的至少一种。一次植入人工角膜还包括中空阶梯轴状的连接环,连接环的材质与镜柱材质相同或相近。连接环的内壁开设有内螺纹,镜柱的前段开设有与内螺纹匹配的外螺纹段;中空阶梯轴状的外壁轴肩处开设有环状凹槽,支架所具有的中心安装孔的内壁以过盈配合的装配方式卡入环状凹槽内;且连接环由前至后卡入支架的中心安装孔。As a possible implementation, the bracket is a metal bracket, and the lens column is at least one of poly(hydroxyethyl methacrylate), poly(methyl methacrylate), bioceramics or optical glass. The one-time implanted artificial cornea also includes a hollow stepped shaft-shaped connecting ring, and the material of the connecting ring is the same as or similar to that of the lens column. The inner wall of the connecting ring is provided with an internal thread, and the front section of the lens column is provided with an external thread section matching the internal thread; an annular groove is provided at the shoulder of the outer wall of the hollow stepped shaft, and the inner wall of the central mounting hole of the bracket is inserted into the annular groove in an interference fit assembly manner; and the connecting ring is inserted into the central mounting hole of the bracket from front to back.

作为一种可能的实现方式,支架的材质与镜柱的材质相同或相近,所述镜柱与支架的中心安装直接连接。As a possible implementation manner, the material of the bracket is the same as or similar to that of the mirror column, and the mirror column is directly connected to the center of the bracket.

作为一种可能的实现方式,支架上开设有便于缝合固定的豁口或针孔。As a possible implementation method, a notch or a needle hole is provided on the bracket to facilitate suturing and fixation.

作为一种可能的实现方式,金属支架以及镜柱本体的非螺纹处具有羟基磷灰石镀膜层。As a possible implementation manner, the non-threaded parts of the metal bracket and the mirror column body are provided with a hydroxyapatite coating layer.

第二方面,本发明还提供一种一次植入人工角膜的使用方法,包括如下步骤:In a second aspect, the present invention further provides a method for using a one-time implanted artificial cornea, comprising the following steps:

S10.将人工角膜镜柱后端连同后盘进入前房;S10. Insert the rear end of the artificial cornea column together with the rear disc into the anterior chamber;

S11.将支架的后盘滑行移动至角膜后表面,使镜柱位于角膜钻孔中央后表面;S11. Slide the rear plate of the bracket to the posterior surface of the cornea so that the lens column is located on the posterior surface of the center of the corneal drilling hole;

S12.缝合角膜放射状侧切口至水密;S12. Suture the radial lateral corneal incision until it is watertight;

S13.旋转支架,直至支架与角膜前表面贴合;S13. Rotate the bracket until it fits the anterior surface of the cornea;

S14.将支架缝合固定在角膜前表面,此时,后盘和支架前后夹持角膜;S14. Suturing and fixing the stent to the anterior surface of the cornea, at this time, the posterior disc and the stent clamp the cornea front and back;

S15.生物组织或人工合成材料加固支架。S15. Biological tissue or artificial synthetic material reinforced scaffold.

与现有技术相比,本发明具有如下效果:Compared with the prior art, the present invention has the following effects:

1.无需供体角膜,一次植入手术即可完成角膜盲复明的治疗,缩短手术期;1. No donor cornea is needed, and a single implantation operation can complete the treatment of corneal blindness and restore vision, shortening the operation period;

2.支架位于角膜前表面,降低手术难度和风险;2. The stent is located on the anterior surface of the cornea, reducing the difficulty and risk of surgery;

3.应用生物组织或人工合成材料实现对人工角膜的有效加固,使得人工角膜更加稳固,提高在位率;3. Use biological tissue or artificial synthetic materials to effectively reinforce the artificial cornea, making it more stable and improving the in-situ rate;

4.角膜被生物组织或人工合成材料覆盖后,相当于其上覆盖有屏障,不仅起到保护的作用,而且能够避免角膜溶解;4. When the cornea is covered with biological tissue or artificial synthetic materials, it is equivalent to being covered with a barrier, which not only plays a protective role but also can prevent corneal dissolution;

5.应用镜柱后端的方边设计,能够有效防止人工角膜后膜的发生;5. The square edge design at the rear end of the lens column can effectively prevent the occurrence of posterior corneal membrane;

6.利用材质与镜柱相同且内壁开设有内螺纹的连接环,或采用相同材质的支架和镜柱,避免在旋转过程中对镜柱本体造成损坏;6. Use a connecting ring with the same material as the mirror column and with internal threads on the inner wall, or use a bracket and mirror column with the same material to avoid damage to the mirror column during rotation;

7.连接环由前至后卡入金属支架的中心安装孔,可以利用中空阶梯轴状的外壁轴肩处开设有环状凹槽,防止连接环的脱落。同时,支架旋转到位后,连接环和金属支架不易分离,即能够完全避免术中连接环脱落至眼球内。7. The connecting ring is inserted into the central mounting hole of the metal bracket from front to back, and the hollow stepped shaft-shaped outer wall shoulder is provided with an annular groove to prevent the connecting ring from falling off. At the same time, after the bracket is rotated into place, the connecting ring and the metal bracket are not easy to separate, which can completely prevent the connecting ring from falling into the eyeball during surgery.

8.金属支架、镜柱侧壁非螺纹段上具有羟基磷灰石镀膜层,提高愈合性。8. The non-threaded section of the metal bracket and the side wall of the mirror column is coated with hydroxyapatite to improve the healing property.

附图说明BRIEF DESCRIPTION OF THE DRAWINGS

此处所说明的附图用来提供对本发明的进一步理解,构成本发明的一部分,本发明的示意性实施例及其说明用于解释本发明,并不构成对本发明的不当限定。The drawings described herein are used to provide further understanding of the present invention and constitute a part of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute improper limitations on the present invention.

图1为本发明实施例提供的人工角膜的整体结构示意图;FIG1 is a schematic diagram of the overall structure of an artificial cornea provided by an embodiment of the present invention;

图2为本发明实施例提供的镜柱的结构示意图;FIG2 is a schematic diagram of the structure of a mirror column provided in an embodiment of the present invention;

图3为本发明实施例提供的支架的结构示意图;FIG3 is a schematic diagram of the structure of a bracket provided in an embodiment of the present invention;

图4为本发明实施例提供的支架用连接环的结构示意图;FIG4 is a schematic structural diagram of a connecting ring for a stent provided in an embodiment of the present invention;

图5为本发明实施例提供的另一支架的结构示意图。FIG. 5 is a schematic structural diagram of another bracket provided in an embodiment of the present invention.

附图标记:Reference numerals:

1-镜柱,10-镜柱本体,11-后盘;1-mirror column, 10-mirror column body, 11-rear plate;

2-支架,20-支架本体,21-连接环,210-内螺纹,211-环形凹槽,212-豁口,213-针孔。2-bracket, 20-bracket body, 21-connecting ring, 210-internal thread, 211-annular groove, 212-notch, 213-pinhole.

具体实施方式DETAILED DESCRIPTION

为了便于清楚描述本发明实施例的技术方案,在本发明的实施例中,采用了“第一”、“第二”等字样对功能和作用基本相同的相同项或相似项进行区分。例如,第一阈值和第二阈值仅仅是为了区分不同的阈值,并不对其先后顺序进行限定。本领域技术人员可以理解“第一”、“第二”等字样并不对数量和执行次序进行限定,并且“第一”、“第二”等字样也并不限定一定不同。In order to clearly describe the technical solutions of the embodiments of the present invention, in the embodiments of the present invention, words such as "first" and "second" are used to distinguish the same items or similar items with basically the same functions and effects. For example, the first threshold and the second threshold are only used to distinguish different thresholds, and their order is not limited. Those skilled in the art can understand that words such as "first" and "second" do not limit the quantity and execution order, and words such as "first" and "second" do not necessarily limit them to be different.

需要说明的是,本发明中,“示例性的”或者“例如”等词用于表示作例子、例证或说明。本发明中被描述为“示例性的”或者“例如”的任何实施例或设计方案不应被解释为比其他实施例或设计方案更优选或更具优势。确切而言,使用“示例性的”或者“例如”等词旨在以具体方式呈现相关概念。It should be noted that, in the present invention, words such as "exemplary" or "for example" are used to indicate examples, illustrations or descriptions. Any embodiment or design described as "exemplary" or "for example" in the present invention should not be interpreted as being more preferred or more advantageous than other embodiments or designs. Specifically, the use of words such as "exemplary" or "for example" is intended to present related concepts in a specific way.

本发明中,“至少一个”是指一个或者多个,“多个”是指两个或两个以上。“和/或”,描述关联对象的关联关系,表示可以存在三种关系,例如,A和/或B,可以表示:单独存在A,同时存在A和B,单独存在B的情况,其中A,B可以是单数或者复数。字符“/”一般表示前后关联对象是一种“或”的关系。“以下至少一项(个)”或其类似表达,是指的这些项中的任意组合,包括单项(个)或复数项(个)的任意组合。例如,a,b或c中的至少一项(个),可以表示:a,b,c,a和b的结合,a和c的结合,b和c的结合,或a、b和c的结合,其中a,b,c可以是单个,也可以是多个。In the present invention, "at least one" means one or more, and "plurality" means two or more. "And/or" describes the association relationship of associated objects, indicating that three relationships may exist. For example, A and/or B can mean: A exists alone, A and B exist at the same time, and B exists alone, where A and B can be singular or plural. The character "/" generally indicates that the associated objects before and after are in an "or" relationship. "At least one of the following" or similar expressions refers to any combination of these items, including any combination of single or plural items. For example, at least one of a, b or c can mean: a, b, c, the combination of a and b, the combination of a and c, the combination of b and c, or the combination of a, b and c, where a, b, c can be single or multiple.

参见图1和图2,本发明实施例提供一种一次植入人工角膜,包括镜柱1和支架2。1 and 2 , an embodiment of the present invention provides a one-time implant artificial cornea, including a lens column 1 and a bracket 2 .

镜柱1包括镜柱本体10以及同轴设置在镜柱本体10靠近后端面处的后盘11;镜柱1与支架2同轴可拆卸的连接。使用状态下,位于后盘11后的镜柱本体10的后端凸入眼内,后盘11贴合角膜后表面且支架2贴合角膜前表面,应用缝合方法将支架2固定在角膜表面,同时,后盘11和支架2夹持角膜。The mirror column 1 includes a mirror column body 10 and a rear plate 11 coaxially arranged near the rear end surface of the mirror column body 10; the mirror column 1 is coaxially detachably connected to the bracket 2. In the use state, the rear end of the mirror column body 10 located behind the rear plate 11 protrudes into the eye, the rear plate 11 fits the rear surface of the cornea and the bracket 2 fits the front surface of the cornea, and the bracket 2 is fixed to the corneal surface by suturing. At the same time, the rear plate 11 and the bracket 2 clamp the cornea.

组装状态下,支架2和镜柱1可以螺纹旋接。In the assembled state, the bracket 2 and the mirror column 1 can be screwed together.

镜柱本体10与后盘11的材质相同,可以一体成型,也可以分别制造完成镜柱本体10和后盘11后,将两者通过任意一种方式同轴紧固连接在一起。The mirror column body 10 and the rear plate 11 are made of the same material and can be integrally formed, or the mirror column body 10 and the rear plate 11 can be manufactured separately and then coaxially fastened together in any manner.

镜柱本体10位于后盘11前方的部分可以是自上而下直径相等的圆柱体结构,与支架2旋接的位置自上而下开设有与支架2的内螺纹210匹配的外螺纹段。The portion of the mirror column body 10 located in front of the rear plate 11 can be a cylindrical structure with equal diameters from top to bottom, and the position screwed to the bracket 2 is provided with an external thread section matching the internal thread 210 of the bracket 2 from top to bottom.

镜柱本体10直径较后盘11直径小。具体的,镜柱本体10直径为2.0~3.5mm。后盘11直径较镜柱本体10直径大2~4mm,即后盘11直径为4~7.5mm。例如,镜柱本体10直径为2mm,后盘11直径为4mm;镜柱本体10直径为3mm,后盘11直径为5mm;镜柱本体10直径为3.5mm,后盘11直径为7.5mm。The diameter of the mirror column body 10 is smaller than that of the rear plate 11. Specifically, the diameter of the mirror column body 10 is 2.0-3.5 mm. The diameter of the rear plate 11 is 2-4 mm larger than that of the mirror column body 10, that is, the diameter of the rear plate 11 is 4-7.5 mm. For example, the diameter of the mirror column body 10 is 2 mm, and the diameter of the rear plate 11 is 4 mm; the diameter of the mirror column body 10 is 3 mm, and the diameter of the rear plate 11 is 5 mm; the diameter of the mirror column body 10 is 3.5 mm, and the diameter of the rear plate 11 is 7.5 mm.

在实际应用中,角膜直径为11mm,钻眼直径为2.5mm。后盘11直径小于或等于角膜半径与镜柱本体10半径的和。In practical applications, the diameter of the cornea is 11 mm, the diameter of the drill hole is 2.5 mm, and the diameter of the rear plate 11 is less than or equal to the sum of the radius of the cornea and the radius of the lens column body 10.

镜柱本体10的总长度为4.5~8.5mm,其中,后盘11至后端面为1~2mm,后盘11至螺纹段段尾的光轴段为0.2~0.5mm,后盘11为0.3~0.5mm,螺纹段为3~5.5mm。The total length of the mirror column body 10 is 4.5-8.5 mm, of which the length from the rear disc 11 to the rear end face is 1-2 mm, the length of the optical axis from the rear disc 11 to the end of the threaded section is 0.2-0.5 mm, the length of the rear disc 11 is 0.3-0.5 mm, and the length of the threaded section is 3-5.5 mm.

镜柱1的屈光度为42~62D,例如,42D、45D、50D、55D、60D或62D。The refractive power of the lens column 1 is 42-62D, for example, 42D, 45D, 50D, 55D, 60D or 62D.

后盘11后方的镜柱本体10的侧面底端至后端面为方边。如此设置,方边周围的生物组织较难越过方边向后端面生长,即能够避免不断生长的生物组织覆盖镜柱1的后端面,从而有效规避镜柱1因被不断生长的生物组织覆盖而无法透光的问题。The side bottom end to the rear end face of the mirror column body 10 behind the rear plate 11 is a square edge. In this way, it is difficult for biological tissues around the square edge to grow over the square edge to the rear end face, that is, it can prevent the growing biological tissues from covering the rear end face of the mirror column 1, thereby effectively avoiding the problem that the mirror column 1 cannot transmit light due to being covered by the growing biological tissues.

方边为直角边、钝角边或锐角边中的一种。后盘11后方的镜柱本体10为等径结构、直径逐渐缩小的结构或直径逐渐增大的结构中的一种。The square edge is one of a right angle edge, an obtuse angle edge or an acute angle edge. The mirror column body 10 behind the rear plate 11 is one of a constant diameter structure, a structure with a gradually decreasing diameter or a structure with a gradually increasing diameter.

后盘11后方的镜柱本体10为等径结构、直径逐渐缩小的结构或直径逐渐增大的结构中的一种。The mirror column body 10 behind the rear plate 11 is one of a structure with a constant diameter, a structure with a gradually decreasing diameter, or a structure with a gradually increasing diameter.

镜柱本体10的非螺纹段上镀羟基磷灰石膜层,利用大气等离子喷涂时,镀膜厚度为30~150微米,粘合强度至少为10Mpa。The non-threaded section of the mirror column body 10 is coated with a hydroxyapatite film. When atmospheric plasma spraying is used, the coating thickness is 30 to 150 microns and the bonding strength is at least 10 MPa.

镜柱本体10构成用于替代眼睛光路的光学器件,即光线透过镜柱本体10后在视网膜上成像。The mirror column body 10 constitutes an optical device for replacing the optical path of the eye, that is, light is imaged on the retina after passing through the mirror column body 10 .

后盘11的外周向前设置有环形外沿,封闭后盘11与角膜后表面,防止漏水以及感染。The outer periphery of the rear disc 11 is provided with an annular outer edge forwardly, which seals the rear disc 11 and the rear surface of the cornea to prevent water leakage and infection.

镜柱1材质为聚甲基丙烯酸羟乙酯、聚甲基丙烯酸甲酯、生物陶瓷或光学玻璃中的至少一种。The mirror column 1 is made of at least one of poly(hydroxyethyl methacrylate), poly(methyl methacrylate), bioceramics or optical glass.

参见图3至图5,支架2可以是金属支架,例如医用金属钛支架。也可以是PMMA支架,即支架2材质与镜柱1材质相同或相近。3 to 5 , the bracket 2 may be a metal bracket, such as a medical titanium bracket, or a PMMA bracket, that is, the material of the bracket 2 is the same as or similar to that of the mirror column 1 .

当支架2为金属支架时,为了缩短支架2与角膜的愈合周期以及提高愈合效果,可以在支架2表面镀一层羟基磷灰石。When the bracket 2 is a metal bracket, in order to shorten the healing period between the bracket 2 and the cornea and improve the healing effect, a layer of hydroxyapatite can be plated on the surface of the bracket 2.

当支架2为金属支架时,一次植入人工角膜还包括中空阶梯轴状的连接环21,连接环21的材质与镜柱1材质相同或相近。连接环21的内壁开设有内螺纹210,镜柱1的前段开设有与内螺纹210匹配的外螺纹段。中空阶梯轴状的外壁轴肩处开设有环状凹槽211,支架2所具有的中心安装孔的内壁以过盈配合的装配方式卡入环状凹槽211内;且连接环21由前至后卡入支架的中心安装孔。When the bracket 2 is a metal bracket, the one-time implantation of the artificial cornea further includes a hollow stepped shaft-shaped connecting ring 21, the material of which is the same or similar to that of the lens column 1. The inner wall of the connecting ring 21 is provided with an internal thread 210, and the front section of the lens column 1 is provided with an external thread section matching the internal thread 210. An annular groove 211 is provided at the shoulder of the outer wall of the hollow stepped shaft, and the inner wall of the central mounting hole of the bracket 2 is inserted into the annular groove 211 in an interference fit assembly manner; and the connecting ring 21 is inserted into the central mounting hole of the bracket from front to back.

当支架2与镜柱1的材质不同但需要以螺纹连接的方式发生相对运动时,金属材质的支架2会对镜柱1的螺纹造成损伤。材质相同的内螺纹和外螺纹段使得两者发生相对位移变化时,最大程度降低旋转运动对彼此的损伤。而且,连接环21由前至后卡入支架的中心安装孔,术中旋转支架2向眼表靠近时,连接环21不会从中心安装孔脱落至眼内。When the bracket 2 and the lens column 1 are made of different materials but need to move relative to each other in a threaded connection, the metal bracket 2 will damage the threads of the lens column 1. The internal and external thread segments of the same material minimize the damage to each other caused by the rotational movement when the two undergo relative displacement changes. In addition, the connecting ring 21 is inserted into the central mounting hole of the bracket from front to back. When the bracket 2 is rotated to approach the ocular surface during surgery, the connecting ring 21 will not fall off from the central mounting hole into the eye.

当支架2与镜柱1均为PMMA时,可以将支架2与镜柱1直接连接,无需上述连接环21。即可以直接在支架2的中心安装孔的内壁开设与外螺纹段匹配的内螺纹210。When the bracket 2 and the mirror column 1 are both made of PMMA, the bracket 2 and the mirror column 1 can be directly connected without the connecting ring 21. That is, an internal thread 210 matching the external thread segment can be directly provided on the inner wall of the central mounting hole of the bracket 2.

从结构上讲,支架2可以是蝶形支架、单圆环支架、双圆环支架(外圆环和内圆环之间具有栅格连接片)或网状支架。其中,网状支架时便于前后组织的营养交换。Structurally, the support 2 can be a butterfly support, a single ring support, a double ring support (with a grid connecting piece between the outer ring and the inner ring) or a mesh support. Among them, the mesh support is convenient for the nutrient exchange of the front and back tissues.

由于支架2需要与角膜的前表面贴合,因此,需要具有一定的弧度,以确保支架2能够完全贴合在角膜的前表面。而且,支架2需要具有一定的刚性,即支架2贴合到角膜前表面后,不容易受力变形或翘曲。支架2还需要具有一定的柔性,由于不同患者的角膜弧度存在差异,因此,具有一定柔性的支架2可以有一定的变形空间,以适应不同弧度的角膜。Since the bracket 2 needs to fit the front surface of the cornea, it needs to have a certain curvature to ensure that the bracket 2 can completely fit the front surface of the cornea. In addition, the bracket 2 needs to have a certain rigidity, that is, after the bracket 2 is attached to the front surface of the cornea, it is not easy to deform or warp under force. The bracket 2 also needs to have a certain flexibility. Since the curvature of the cornea varies from patient to patient, the bracket 2 with a certain flexibility can have a certain deformation space to adapt to corneas with different curvatures.

支架2上开设有便于缝合固定的豁口212或针孔213。如此设置,便于将支架2缝合固定在眼表。角膜放射状侧切口缝合后,将人角膜固定在角膜后表面,待支架2移动至与角膜前表面贴合后,再利用豁口212或者是针孔213将支架2与角膜缝合。The bracket 2 is provided with a notch 212 or a pinhole 213 for suturing and fixing. This arrangement facilitates the bracket 2 to be sutured and fixed to the ocular surface. After the radial side incision of the cornea is sutured, the human cornea is fixed to the posterior surface of the cornea, and after the bracket 2 is moved to fit the anterior surface of the cornea, the notch 212 or the pinhole 213 is used to suture the bracket 2 and the cornea.

角膜外还缝合有用于加固支架2的生物组织或人工合成材料。生物组织覆盖支架2且包绕镜柱1。起到同时加固支架2和镜柱1的作用。组织由后向前依次为耳软骨、Tenon's囊和上皮组织。人工合成材料可以是羟基磷灰石、人工骨。Biological tissue or artificial synthetic material for reinforcing the bracket 2 is also sutured outside the cornea. The biological tissue covers the bracket 2 and surrounds the lens column 1. It plays the role of reinforcing the bracket 2 and the lens column 1 at the same time. The tissues are ear cartilage, Tenon's capsule and epithelial tissue from back to front. The artificial synthetic material can be hydroxyapatite or artificial bone.

在具体应用时,可以取患者自身的耳软骨,耳软骨对应镜柱1的位置钻孔,将耳软骨与角膜缝合,包绕镜柱1且覆盖支架2。实现对人工角膜的二次加固,使得人工角膜更加稳固,不易脱位。另外,角膜被耳软骨覆盖后,相当于其上覆盖有屏障,不仅起到保护的作用,而且能够避免角膜溶解。In specific applications, the patient's own ear cartilage can be taken, a hole is drilled in the ear cartilage corresponding to the position of the mirror column 1, and the ear cartilage is sutured to the cornea, wrapping around the mirror column 1 and covering the bracket 2. The secondary reinforcement of the artificial cornea is achieved, making the artificial cornea more stable and not easy to dislocate. In addition, after the cornea is covered with ear cartilage, it is equivalent to covering it with a barrier, which not only plays a protective role, but also can prevent the cornea from dissolving.

在耳软骨的前表面,还进一步的覆盖有Tenon's囊,其属于眼表的生物质囊,具有一定的柔性和弹性,利用Tenon's囊能够实现对人工角膜的三次加固。The front surface of the ear cartilage is further covered with a Tenon's capsule, which is a biomass capsule on the surface of the eye and has a certain degree of flexibility and elasticity. The Tenon's capsule can be used to achieve three reinforcements of the artificial cornea.

支架2外周尺寸8.5mm~10mm,例如,支架2外周尺寸为8.5mm、9.0mm、9.5mm或10mm。The outer circumference size of the bracket 2 is 8.5 mm to 10 mm. For example, the outer circumference size of the bracket 2 is 8.5 mm, 9.0 mm, 9.5 mm or 10 mm.

支架2的曲率半径为7.8mm±2.0mm。例如,支架2的曲率半径为5.8mm、6.8mm、7.8mm、8.8mm或9.8mm。The curvature radius of the bracket 2 is 7.8 mm ± 2.0 mm. For example, the curvature radius of the bracket 2 is 5.8 mm, 6.8 mm, 7.8 mm, 8.8 mm or 9.8 mm.

通过如下方式将本发明提供的人工角膜植入严重角膜盲患者的眼内,达到复明的目的。即在患者角膜中央利用环钻打孔,并在孔的一侧侧切以形成角膜放射状侧切口,改善手术视野,便于晶体完整取出,或解决了现有技术存在的晶体皮质残留的问题。The artificial cornea provided by the present invention is implanted into the eyes of patients with severe corneal blindness in the following manner to achieve the purpose of restoring sight: a hole is drilled in the center of the patient's cornea, and a side cut is made on one side of the hole to form a radial side incision of the cornea, thereby improving the surgical field of view, facilitating the complete removal of the lens, or solving the problem of residual lens cortex in the prior art.

取出晶状体以及切除前部玻璃体后,将人工角膜所包括得后盘11植入上述钻孔内,即后盘11通过角膜放射状侧切口进入角膜后与其后表面贴合。此时,可以将角膜放射状侧切口缝合,以使镜柱1初步固定。在此基础上,旋转支架2,以使支架2向后移动,当支架2与角膜前表面贴合时,支架2和后盘11一前一后夹持在角膜上,将支架2与角膜缝合在一起,以实现支架2在眼表的固定。After the lens is removed and the anterior vitreous body is removed, the posterior disc 11 included in the artificial cornea is implanted into the above-mentioned drilled hole, that is, the posterior disc 11 enters the cornea through the radial side incision of the cornea and fits with its rear surface. At this time, the radial side incision of the cornea can be sutured to preliminarily fix the lens column 1. On this basis, the bracket 2 is rotated to move the bracket 2 backward. When the bracket 2 fits with the front surface of the cornea, the bracket 2 and the posterior disc 11 are clamped on the cornea one after the other, and the bracket 2 and the cornea are sutured together to achieve the fixation of the bracket 2 on the ocular surface.

从上述应用过程可知,本发明提供的人工角膜仅需要一次手术即可完成角膜盲复明的治疗,缩短手术期,能够降低患者等待的焦虑和多次手术的痛苦。而且,利用患者自体角膜实现对支架2的初步固定,无需供体角膜,可以完全避免供体角膜缺乏及异体角膜移植排斥。另外,支架2位于角膜前表面,相对于现有技术提供的支架植入角膜板层内,手术难度和风险大大降低、创伤小以及愈合周期短且愈合效果好。From the above application process, it can be known that the artificial cornea provided by the present invention only requires one operation to complete the treatment of corneal blindness and restoration of vision, shortening the operation period, and reducing the patient's anxiety of waiting and the pain of multiple operations. Moreover, the initial fixation of the bracket 2 is achieved by using the patient's own cornea, without the need for a donor cornea, which can completely avoid the lack of donor corneas and rejection of allogeneic corneal transplants. In addition, the bracket 2 is located on the front surface of the cornea. Compared with the bracket provided by the prior art that is implanted in the corneal lamella, the difficulty and risk of the operation are greatly reduced, the trauma is small, the healing period is short, and the healing effect is good.

在实际应用中,当后盘11与镜柱本体10一体成型时,通过如下方式组装在一起:In practical applications, when the rear disc 11 and the mirror column body 10 are integrally formed, they are assembled together in the following manner:

a.将连接环21自上而下卡入支架2的中心安装孔;a. Insert the connecting ring 21 into the center mounting hole of the bracket 2 from top to bottom;

b.镜柱本体10的前端贯穿连接环21(或中心安装孔具有的内螺纹孔)的内螺纹210,以相反的方向旋转镜柱本体20和支架2,以使支架2沿镜柱本体10的轴向向靠近后盘11的方向移动。b. The front end of the mirror column body 10 passes through the internal thread 210 of the connecting ring 21 (or the internal thread hole of the center mounting hole), and the mirror column body 20 and the bracket 2 are rotated in opposite directions to move the bracket 2 along the axial direction of the mirror column body 10 toward the rear disk 11.

第二方面,本发明实施例还提供一种一次植入人工角膜的使用方法,应用本发明实施例提供的人工角膜前,首先需要确定植入位置位居角膜中央,在角膜中央用环钻打孔,并做一个角膜放射状侧切口。使用方法包括如下步骤:In a second aspect, the embodiment of the present invention also provides a method for using an artificial cornea that is implanted once. Before using the artificial cornea provided by the embodiment of the present invention, it is first necessary to determine that the implantation position is located in the center of the cornea, drill a hole in the center of the cornea with a trephine, and make a radial side incision of the cornea. The method of use comprises the following steps:

S10.将人工角膜镜柱后端连同后盘植入前房;S10. Implant the rear end of the artificial cornea column together with the posterior disc into the anterior chamber;

S11.将支架的后盘滑行移动至角膜中央的后表面;S11. Slide the rear disc of the bracket to the rear surface of the center of the cornea;

S12.缝合角膜放射状侧切口至水密;S12. Suture the radial lateral corneal incision until it is watertight;

S13.旋转支架,直至支架与角膜前表面贴合;S13. Rotate the bracket until it fits the anterior surface of the cornea;

S14.将支架缝合固定在眼球前表面,此时,后盘和支架前后夹持角膜;S14. Suture and fix the stent to the anterior surface of the eyeball. At this time, the posterior disc and the stent clamp the cornea front and back;

S15.生物组织或人工材料加固支架。S15. Biological tissue or artificial material reinforced scaffold.

作为一种示例,S15具体包括:As an example, S15 specifically includes:

S150.取患者的耳软骨,并在耳软骨对应镜柱本体的钻孔。将耳软骨通过孔包绕镜柱本体且覆盖支架,同时缝合耳软骨和角膜。S150. Take the patient's ear cartilage, and drill a hole in the ear cartilage corresponding to the mirror column body. Pass the ear cartilage through the hole to wrap around the mirror column body and cover the bracket, and suture the ear cartilage and cornea at the same time.

S151.将Tenon's囊扯平整覆盖在耳软骨的表面,并与耳软骨缝合在一起。S151. Flatten the Tenon's capsule and cover it on the surface of the ear cartilage, and sew it together with the ear cartilage.

尽管在此结合各实施例对本发明进行了描述,然而,在实施所要求保护的本发明过程中,本领域技术人员通过查看附图、公开内容、以及附图等,可理解并实现公开实施例的其他变化。在说明书中,“包括”(comprising)一词不排除其他组成部分或步骤,“一”或“一个”不排除多个的情况。单个处理器或其他单元可以实现说明书中列举的若干项功能。相互不同的实施例中记载了某些措施,但这并不表示这些措施不能组合起来产生良好的效果。Although the present invention is described herein in conjunction with various embodiments, in the process of implementing the claimed invention, those skilled in the art may understand and implement other variations of the disclosed embodiments by viewing the drawings, the disclosure, and the drawings, etc. In the specification, the word "comprising" does not exclude other components or steps, and "one" or "an" does not exclude multiple situations. A single processor or other unit can implement several functions listed in the specification. Certain measures are recorded in different embodiments, but this does not mean that these measures cannot be combined to produce good results.

尽管结合具体特征及其实施例对本发明进行了描述,显而易见的,在不脱离本发明的精神和范围的情况下,可对其进行各种修改和组合。相应地,本说明书和附图仅仅是本发明的示例性说明,且视为已覆盖本发明范围内的任意和所有修改、变化、组合或等同物。显然,本领域的技术人员可以对本发明进行各种改动和变型而不脱离本发明的精神和范围。这样,倘若本发明的这些修改和变型属于本发明及其等同技术的范围之内,则本发明也意图包括这些改动和变型在内。Although the present invention has been described in conjunction with specific features and embodiments thereof, it is apparent that various modifications and combinations may be made thereto without departing from the spirit and scope of the present invention. Accordingly, this specification and the accompanying drawings are merely exemplary illustrations of the present invention and are deemed to cover any and all modifications, variations, combinations or equivalents within the scope of the present invention. Obviously, those skilled in the art may make various modifications and variations to the present invention without departing from the spirit and scope of the present invention. Thus, the present invention is intended to include such modifications and variations if they fall within the scope of the present invention and its equivalents.

Claims (10)

1.一种一次植入人工角膜,包括支架和镜柱,其特征在于,所述镜柱包括镜柱本体以及同轴设置在所述镜柱本体靠近后端面处的后盘;所述镜柱与所述支架同轴可拆卸的连接;使用状态下,位于所述后盘后的镜柱本体的后端凸入眼内,所述后盘贴合角膜后表面且所述支架贴合角膜前表面,应用缝合方法将支架固定在角膜前表面,实现支架和后盘前后夹持角膜。1. A one-time implantable artificial cornea, comprising a bracket and a lens column, characterized in that the lens column comprises a lens column body and a rear disc coaxially arranged at the rear end surface of the lens column body; the lens column and the bracket are coaxially detachably connected; in a use state, the rear end of the lens column body located behind the rear disc protrudes into the eye, the rear disc fits the rear surface of the cornea and the bracket fits the front surface of the cornea, and the bracket is fixed to the front surface of the cornea by a suturing method, so that the bracket and the rear disc clamp the cornea front and back. 2.根据权利要求1所述的一次植入人工角膜,其特征在于,所述后盘后方的镜柱本体的侧面底端至后端面为方边;和/或,后盘的外周向前设置有环形外沿,以封闭后盘与角膜后表面。2. The one-time implantable artificial cornea according to claim 1 is characterized in that the side bottom end to the rear end face of the lens column body behind the rear disc is a square edge; and/or, the outer periphery of the rear disc is provided with an annular outer edge forward to seal the rear disc and the rear surface of the cornea. 3.根据权利要求2所述的一次植入人工角膜,其特征在于,所述方边为直角边、钝角边或锐角边中的一种。3. The one-time implant artificial cornea according to claim 2, characterized in that the square edge is one of a right-angled edge, an obtuse-angled edge or an acute-angled edge. 4.根据权利要求3所述的一次植入人工角膜,其特征在于,所述后盘后方的镜柱本体为等径结构、直径逐渐缩小的结构或直径逐渐增大的结构中的一种。4. The one-time implantable artificial cornea according to claim 3 is characterized in that the lens column body behind the posterior disc is one of an equal-diameter structure, a structure with a gradually decreasing diameter, or a structure with a gradually increasing diameter. 5.根据权利要求1所述的一次植入人工角膜,其特征在于,角膜前表面缝合有用于加固所述支架的生物组织或人工合成材料。5. The one-time implant artificial cornea according to claim 1 is characterized in that biological tissue or artificial synthetic material for reinforcing the support is sutured on the front surface of the cornea. 6.根据权利要求5所述的一次植入人工角膜,其特征在于,所述生物组织由内至外依次包括耳软骨和Tenon's囊;6. The one-time implant artificial cornea according to claim 5, characterized in that the biological tissues include ear cartilage and Tenon's capsule from inside to outside; 所述人工合成材料为羟基磷灰石、人工骨。The artificial synthetic materials are hydroxyapatite and artificial bone. 7.根据权利要求1所述的一次植入人工角膜,其特征在于,所述支架为金属支架,所述镜柱为聚甲基丙烯酸羟乙酯、聚甲基丙烯酸甲酯、生物陶瓷或光学玻璃中的至少一种;7. The one-time implant artificial cornea according to claim 1, characterized in that the bracket is a metal bracket, and the mirror column is at least one of polyhydroxyethyl methacrylate, polymethyl methacrylate, bioceramics or optical glass; 所述一次植入人工角膜还包括中空阶梯轴状的连接环,所述连接环的材质与所述镜柱材质相同或相近;所述连接环的内壁开设有内螺纹,所述镜柱本体的前段开设有与所述内螺纹匹配的外螺纹;所述中空阶梯轴状的外壁轴肩处开设有环状凹槽,所述支架所具有的中心安装孔的内壁以过盈配合的装配方式卡入所述环状凹槽内;且所述连接环由前至后卡入所述支架的中心安装孔。The one-time implanted artificial cornea also includes a hollow stepped shaft-shaped connecting ring, the material of the connecting ring is the same as or similar to the material of the mirror column; the inner wall of the connecting ring is provided with an internal thread, and the front section of the mirror column body is provided with an external thread matching the internal thread; the outer wall shoulder of the hollow stepped shaft is provided with an annular groove, and the inner wall of the central mounting hole of the bracket is inserted into the annular groove in an interference fit assembly manner; and the connecting ring is inserted into the central mounting hole of the bracket from front to back. 8.根据权利要求1所述的一次植入人工角膜,其特征在于,所述支架的材质与镜柱的材质相同或相近,所述镜柱与支架的中心安装孔直接连接。8. The one-time implantable artificial cornea according to claim 1 is characterized in that the material of the bracket is the same as or similar to the material of the lens column, and the lens column is directly connected to the central mounting hole of the bracket. 9.根据权利要求1所述的一次植入人工角膜,其特征在于,所述支架上开设有便于缝合固定的豁口或针孔;和/或,所述金属支架以及镜柱本体的非螺纹处具有羟基磷灰石镀膜层。9. The one-time implant artificial cornea according to claim 1 is characterized in that a notch or a pinhole is provided on the bracket for suturing and fixation; and/or the non-threaded parts of the metal bracket and the lens column body have a hydroxyapatite coating layer. 10.一种一次植入人工角膜的使用方法,其特征在于,包括如下步骤:10. A method for using a one-time implanted artificial cornea, characterized in that it comprises the following steps: S10.将人工角膜镜柱后端连同后盘进入前房;S10. Insert the rear end of the artificial cornea column together with the rear disc into the anterior chamber; S11.将支架的后盘滑行移动至角膜后表面,使镜柱位于角膜钻孔中央;S11. Slide the rear plate of the bracket to the posterior surface of the cornea so that the lens column is located in the center of the corneal hole; S12.缝合角膜放射状侧切口至水密;S12. Suture the radial lateral corneal incision until it is watertight; S13.旋转支架,直至支架与角膜前表面贴合;S13. Rotate the bracket until it fits the anterior surface of the cornea; S14.将支架缝合固定在角膜前表面,此时,后盘和支架前后夹持角膜;S14. Suturing and fixing the stent to the anterior surface of the cornea, at this time, the posterior disc and the stent clamp the cornea front and back; S15.生物组织或人工材料加固支架。S15. Biological tissue or artificial material reinforced scaffold.
CN202411029920.6A 2024-07-30 2024-07-30 One-time implantation artificial cornea and use method thereof Active CN118845297B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202411029920.6A CN118845297B (en) 2024-07-30 2024-07-30 One-time implantation artificial cornea and use method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202411029920.6A CN118845297B (en) 2024-07-30 2024-07-30 One-time implantation artificial cornea and use method thereof

Publications (2)

Publication Number Publication Date
CN118845297A true CN118845297A (en) 2024-10-29
CN118845297B CN118845297B (en) 2025-06-27

Family

ID=93175307

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202411029920.6A Active CN118845297B (en) 2024-07-30 2024-07-30 One-time implantation artificial cornea and use method thereof

Country Status (1)

Country Link
CN (1) CN118845297B (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6106552A (en) * 1996-01-30 2000-08-22 Corneal Industrie Corneal prosthesis device having anterior and posterior annular skirts
US20150216651A1 (en) * 2012-09-05 2015-08-06 University Of Miami Novel keratoprosthesis, and system and method of corneal repair using same
CN110025402A (en) * 2019-05-21 2019-07-19 王丽强 Artificial cornea containing biomaterial
CN113662707A (en) * 2021-07-28 2021-11-19 天津世纪康泰生物医学工程有限公司 Artificial lens for correcting high myopia
CN116942364A (en) * 2023-09-18 2023-10-27 上海视科新工医疗器械有限公司 Artificial cornea
CN117338476A (en) * 2023-09-28 2024-01-05 长沙宏达医疗设备有限公司 Artificial cornea in cornea stroma and preparation method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6106552A (en) * 1996-01-30 2000-08-22 Corneal Industrie Corneal prosthesis device having anterior and posterior annular skirts
US20150216651A1 (en) * 2012-09-05 2015-08-06 University Of Miami Novel keratoprosthesis, and system and method of corneal repair using same
CN110025402A (en) * 2019-05-21 2019-07-19 王丽强 Artificial cornea containing biomaterial
CN113662707A (en) * 2021-07-28 2021-11-19 天津世纪康泰生物医学工程有限公司 Artificial lens for correcting high myopia
CN116942364A (en) * 2023-09-18 2023-10-27 上海视科新工医疗器械有限公司 Artificial cornea
CN117338476A (en) * 2023-09-28 2024-01-05 长沙宏达医疗设备有限公司 Artificial cornea in cornea stroma and preparation method thereof

Also Published As

Publication number Publication date
CN118845297B (en) 2025-06-27

Similar Documents

Publication Publication Date Title
Dahan et al. Pseudophakia in children: precautions, technique, and feasibility
AU667342B2 (en) Corneal ring inlay and methods of use
Chun et al. Iris and trabecular meshwork pigment changes after posterior chamber phakic intraocular lens implantation
Aquavella et al. Keratoprosthesis: the Dohlman-Doane device
US20030097151A1 (en) Apparatus and mitochondrial treatment for glaucoma
US20010044657A1 (en) Phakic or aphakic intraocular lens assembly
JPS5848182B2 (en) Posterior ventricular intraocular lens
Refojo Current status of biomaterials in ophthalmology
US4923466A (en) Kerato-prosthesis for transcorneal implantation and process of manufacture thereof
CN201782846U (en) Artificial cornea
RU2367379C1 (en) Keratoprosthesis and leukoma surgery therewith
Liu et al. Keratoprosthesis surgery
CN113599020A (en) Artificial cornea integrating refractive function of crystalline lens
CN118845297A (en) One-time implantation of artificial cornea and method of use thereof
RU2100984C1 (en) Irido-lenticular diaphragm of the eye
CN218784470U (en) Intraocular lens capsular bag
Choyce The Long-Term Effects of Ocular Implants [Abridged] Long-Term Tolerance of Choyce Mk I and Mk VIII Anterior Chamber Implants
CN209966660U (en) Artificial cornea
CN220069927U (en) Artificial cornea integrating lens refractive function
CN212575021U (en) Integrated veterinary intraocular lens
CN118766650A (en) A one-time implantable artificial cornea imitating human eyes and its use method
RU95103019A (en) Method to form cavity for artificial eye
CN208145079U (en) A kind of interim cornea of novel artificial
CN223095678U (en) A bracket for artificial cornea
Maguen et al. Broken semiflexible intraocular lens implant

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant